Comparative Pharmacology
Head-to-head clinical analysis: PITRESSIN TANNATE versus STIMATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PITRESSIN TANNATE versus STIMATE.
PITRESSIN TANNATE vs STIMATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Pitressin Tannate is a synthetic form of vasopressin (antidiuretic hormone) that acts on V2 receptors in the renal collecting ducts to increase water reabsorption, and on V1 receptors to cause vasoconstriction.
Desmopressin acetate is a synthetic analog of the natural pituitary hormone 8-arginine vasopressin (ADH). It acts as a V2 receptor agonist in the renal collecting ducts, increasing water permeability and promoting water reabsorption, thereby reducing urine output. It also increases plasma levels of von Willebrand factor and factor VIII via V2 receptor stimulation on endothelial cells.
0.5-1 mL (5-10 units) intramuscularly or subcutaneously every 24-48 hours as needed for diabetes insipidus.
Intranasal: 1 spray (1.5 mg) into one nostril, 1 hour prior to voiding or on awakening for bedwetting; maximum 2 sprays per day.
None Documented
None Documented
Clinical Note
moderateNorgestimate + Atazanavir
"The serum concentration of Atazanavir can be increased when it is combined with Norgestimate."
Clinical Note
moderateNorgestimate + Fosamprenavir
"The serum concentration of the active metabolites of Fosamprenavir can be reduced when Fosamprenavir is used in combination with Norgestimate resulting in a loss in efficacy."
Clinical Note
moderateNorgestimate + Cobicistat
"The serum concentration of Cobicistat can be increased when it is combined with Norgestimate."
Clinical Note
moderateTerminal elimination half-life approximately 15 minutes (range 10–20 minutes). Clinically, due to rapid clearance, effects are short-lived; continuous infusion or depot formulations are required for sustained effect.
Terminal elimination half-life is approximately 3-4 hours in healthy adults, but may be prolonged in patients with renal impairment or in older adults.
Primarily renal: >95% of administered dose excreted unchanged in urine within 24 hours. Biliary/fecal elimination negligible (<5%).
Desmopressin is primarily excreted renally, with approximately 60-70% of the dose recovered unchanged in urine within 24 hours. The remaining fraction is metabolized hepatically and eliminated via feces.
Category C
Category C
Antidiuretic Hormone Analog
Antidiuretic Hormone Analog
Norgestimate + Boceprevir
"The serum concentration of Boceprevir can be increased when it is combined with Norgestimate."